Translation of Addictions Science Into Practice

513 Pages·2007·3.51 MB·English

by  Peter M. Miller

Else_TASP-MILLER_prelims.qxd 2/28/2007 11:39 Page i
Translation of Addictions Science into Practice
This page intentionally left blank
Else_TASP-MILLER_prelims.qxd 2/28/2007 11:39 Page iii
Translation of Addictions Science
into Practice
Edited by
Peter M. Miller, Ph.D.
Center for Drug and Alcohol Programs
Department of Psychiatry and Behavioural Sciences
Medical University of South Carolina
Charleston, SC 29425, USA
and
David J. Kavanagh, Ph.D.
School of Medicine
University of Queensland
Herston 4029
Australia
Amsterdam ● Boston ● Heidelberg ● London ● New York
● Oxford ● Paris ● San Diego ● San Francisco
● Singapore ● Sydney ● Tokyo
Pergamon is an imprint of Elsevier
Else_TASP-MILLER_prelims.qxd 2/28/2007 11:39 Page iv
Pergamon is an imprint of Elsevier
525 B Street, Suit 1900, San Diego, CA 92101-4495, USA
Linacre House, Jordan Hill, Oxford OX2 8DP, UK
Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands
First edition 2007
Copyright © 2007 Elsevier Ltd. All rights reserved
No part of this publication may be reproduced, stored in a retrieval system
or transmitted in any form or by any means electronic, mechanical, photocopying,
recording or otherwise without the prior written permission of the publisher
Permissions may be sought directly from Elsevier’s Science & Technology Rights
Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333;
email: [email protected]. Alternatively you can submit your request online by
visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting
Obtaining permission to use Elsevier material
Notice
No responsibility is assumed by the publisher for any injury and/or damage to persons
or property as a matter of products liability, negligence or otherwise, or from any use
or operation of any methods, products, instructions or ideas contained in the material
herein. Because of rapid advances in the medical sciences, in particular, independent
verification of diagnoses and drug dosages should be made
British Library Cataloguing in Publication Data
Translation of addictions science into practice
1. Substance abuse 2. Substance abuse - Treatment
3. Substance abuse - Treatment - Psychological aspects
I. Miller, Peter M. (Peter Michael), 1942- II. Kavanagh,
David John
616.8'6
Library of Congress Cataloging-in-Publication Data
A catalog record for this book is available from the Library of Congress
ISBN: 978-0-08-044927-2
For information on all Pergamon publications
visit our website at books.elsevier.com
Printed and bound in The Netherlands
07 08 09 10 11 10 9 8 7 6 5 4 3 2 1
Else_TASP-MILLER_Contents.qxd 2/26/2007 5:47 PM Page v
TABLE OF CONTENTS
List of Contributors ix
Preface xiii
SECTION I: GENETICS AND NEUROSCIENCE
Chapter 1 The Interplay between Genotype and Gene
Expression in Human Brain:What Can it
Teach Us about Alcohol Dependence?
P. R. Dodd 3
Chapter 2 Common Genetic Influences on Antisociality
and Addictions: Implications for Clinical Science
and Practice
S. M. King 23
Chapter 3 Opioids, Pain and Addiction: Cause and
Consequence
J. M. White and J. L. Hay 39
Chapter 4 Imbalance between Neuroexcitatory and
Neuroinhibitory Amino Acids causes Craving
for Ethanol: From Animal to Human Being Studies
P. De Witte 57
Chapter 5 Cannabis and the Brain: Implications of Recent
Research
S. Sundram and D. Castle 81
SECTION II: PHARMACOTHERAPY
Chapter 6 The Plasticity of Alcohol Addiction Suggests
Novel Approaches to Pharmacological Intervention
P. J. Mulholland and L. J. Chandler 103
v
Else_TASP-MILLER_Contents.qxd 2/26/2007 5:47 PM Page vi
vi Table of Contents
Chapter 7 Pharmacotherapies for the Treatment
of Alcohol Dependence: Current and
on the Horizon
T. M. Wright, A. M. Baros and R. F. Anton 123
Chapter 8 Agonist Treatment for Stimulant Abuse and
Dependence
D. Herin and J. Grabowski 145
Chapter 9 Topiramate-Induced Neuromodulation of
Cortico-Mesolimbic Dopamine: Implications
for the Treatment of Nicotine and Alcohol
Dependence
B. A. Johnson 169
SECTION III: PSYCHOLOGY AND SOCIOLOGY
Chapter 10 Advances in the Scientific Study of Craving
for Alcohol and Tobacco
J. MacKillop and P. M. Monti 189
Chapter 11 Advances in the Treatment of Craving
for Alcohol and Tobacco
P. M. Monti and J. MacKillop 211
Chapter 12 Cognitive, Affective and Motivational Effects
of Smoking
J. Powell and L. Dawkins 239
Chapter 13 Therapeutic Outcome Research
and Dissemination of Empirically Based
Treatment for Alcohol Use Disorders
P. Wilbourne and K. Weingardt 259
Chapter 14 Implications of Research on Comorbidity
for the Nature and Management
of Substance Misuse
K. T. Mueser, D. J. Kavanagh
and M. F. Brunette 277
Else_TASP-MILLER_Contents.qxd 2/26/2007 5:47 PM Page vii
Table of Contents vii
Chapter 15 The Role of Impulsive Personality Traits
in the Initiation, Development, and Treatment
of Substance Misuse Problems
S. Dawe, N. J. Loxton, M. J. Gullo, P. K. Staiger,
N. Kambouropoulos, L. Perdon and A. Wood 321
Chapter 16 Translational Research Involving Adolescent
Substance Abuse
J. R. Cornelius and D. B. Clark 341
SECTION IV: PRACTICE AND POLICY
Chapter 17 Dissemination of Evidence-Based Treatment
into Substance Abuse Clinical Practice
J. L. Sorensen, J. E. Hettema and T. Chen 363
Chapter 18 Alcohol Screening and Intervention in Medical
and Surgical Settings
S. H. Stewart and P. M. Miller 379
Chapter 19 Internet-Based Interventions for Alcohol,
Tobacco and Other Substances of Abuse
J. A. Cunningham 399
Chapter 20 Alcohol Use Among Undergraduate Students:
From Brief Interventions to Behavioral Economics
A. M. Henslee, J. G. Irons and C. J. Correia 417
Chapter 21 Ethical and Policy Issues in the Translation
of Genetic and Neuroscience Research
on Addiction
A. Carter and W. Hall 439
SECTION V: CONCLUSION
Chapter 22 Pathways to Innovation in Addiction Practice
D. J. Kavanagh and P. M. Miller 461
Subject Index 473
This page intentionally left blank
Else_TASP-MILLER_loc.qxd 3/27/2007 06:42 Page ix
LIST OF CONTRIBUTORS
Numbers in parentheses indicate the pages on which the authors’ contributions begins
Raymond F.Anton (123), Center for Drug and Alcohol Programs, Department
of Psychiatry and Behavioral Sciences, Medical University of South
Carolina, 67 President Street, Charleston, SC 29425, USA
Alicia M.Baros (123), Center for Drug and Alcohol Programs, Department
of Psychiatry and Behavioral Sciences, Medical University of South
Carolina, 67 President Street, Charleston, SC 29425, USA
Mary F. Brunette (275), New Hampshire-Dartmouth Psychiatric Research
Center, Concord, NH 03301, USA
Adrian Carter (437), Queensland Brain Institute, University of Queensland,
St. Lucia, Queensland 4072, Australia
David Castle (81), Mental Health Research Institute of Victoria, Parkville,
Victoria 3052, Australia
L.Judson Chandler (103), Department of Neurosciences and Center for Drug
and Alcohol Programs, Medical University of South Carolina, Charleston,
SC 29425, USA
TeChieh Chen (361), University of California at San Francisco, San Francisco,
CA 94110, USA
Duncan B.Clark (339), Department of Psychiatry and Pharmaceutical Sciences,
Western Psychiatric Institute and Clinic, University of Pittsburgh, School
of Medicine, Pittsburgh, PA 15213, USA
Jack R.Cornelius (339), Department of Psychiatry and Pharmaceutical Sciences,
Western Psychiatric Institute and Clinic, University of Pittsburgh, School
of Medicine, Pittsburgh, PA 15213, USA
Christopher J.Correia (415), Department of Psychology, Auburn University,
Auburn, AL 36849-5214, USA
John A. Cunningham (397), Centre for Addiction and Mental Health,
Toronto, Ontario, Canada M5S 2S1
Sharon Dawe (319), Griffith University, School of Psychology, Brisbane,
Queensland 4111, Australia
Lynne Dawkins (237), School of Psychology, University of East London,
London E15 4LZ, UK
Philippe De Witte (57), UCL – Biologie du Comportement, B-1348 Louvain-
la-Neuve, Belgium
ix